Valuation: Camurus AB

Market Cap 37.55B 3.88B 3.4B 3.15B 2.9B 5.46B 374B 5.54B 14.7B 183B 14.55B 14.23B 632B P/E 2026 *
39.5x
P/E 2027 * 25.5x
Enterprise Value 32.99B 3.4B 2.98B 2.77B 2.54B 4.79B 328B 4.87B 12.91B 161B 12.78B 12.5B 555B EV / Sales 2026 *
11.6x
EV / Sales 2027 * 8.37x
Free-Float
66.89%
Yield 2026 *
-
Yield 2027 * -
1 day+1.69%
1 week+2.60%
Current month+11.58%
1 month+22.64%
3 months+10.99%
6 months-8.48%
Current year+2.44%
1 week 609
Extreme 609
645
1 month 525.5
Extreme 525.5
645
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
754.5
3 years 279.2
Extreme 279.2
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2003
Director of Finance/CFO 57 01/07/2025
Chief Tech/Sci/R&D Officer 58 01/01/2025
Director TitleAgeSince
Director/Board Member 63 01/01/2002
Chairman 77 01/01/2015
Director/Board Member 61 07/05/2020
Date Insider Type Main position Quantity % Market Cap.
2/27/26 A Sell

Chief Executive Officer

55,550 0.0928%
2/27/26 A Sell

Chief Executive Officer

9,950 0.0166%
2/27/26 A Sell

Chief Executive Officer

1,500 0.0025%
Change 5-day change 1-year change 3-year change Capi.($)
+1.69%+2.60%-9.47%+106.48% 3.88B
-1.05%+0.55%+49.79%+151.71% 1,037B
+2.00%+3.49%+52.22%+50.20% 615B
-1.09%+3.76%+35.37%+76.22% 448B
-0.42%+0.67%+30.81%+21.05% 326B
-0.16%+2.74%+36.02%+37.33% 293B
+1.68%+1.08%+22.70%+17.94% 264B
-1.40%-3.34%-24.63%-42.39% 216B
-0.05%+2.16%+19.75%+55.89% 198B
+0.05%-1.03%+18.31%+61.63% 162B
Average -0.08%+1.27%+23.09%+53.61% 356.13B
Weighted average by Cap. -0.46%+1.48%+35.85%+72.21%

Financials

2026 *2027 *
Net sales 2.85B 294M 257M 239M 220M 414M 28.35B 420M 1.11B 13.87B 1.1B 1.08B 47.92B 3.79B 391M 343M 318M 292M 551M 37.75B 559M 1.48B 18.47B 1.47B 1.44B 63.8B
Net income 968M 99.92M 87.55M 81.27M 74.68M 141M 9.64B 143M 379M 4.72B 375M 367M 16.3B 1.45B 150M 131M 122M 112M 211M 14.47B 214M 569M 7.08B 563M 551M 24.46B
Net Debt -4.56B -471M -413M -383M -352M -663M -45.44B -673M -1.79B -22.24B -1.77B -1.73B -76.81B -5.81B -599M -525M -487M -448M -844M -57.83B -856M -2.27B -28.3B -2.25B -2.2B -97.75B
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
316
Date Price Change Volume
22/07/26 SEK 631.00 +1.69% 46,530
21/07/26 SEK 620.50 +0.24% 106,406
20/07/26 SEK 619.00 -1.51% 47,024
17/07/26 SEK 628.50 -1.64% 67,377
16/07/26 SEK 639.00 +3.90% 109,880
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
631.00SEK
Average target price
776.75SEK
Spread / Average Target
+23.10%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMX Stock